HBM-Luc Citations (2)

Originally described in: The Myc negative autoregulation mechanism requires Myc-Max association and involves the c-myc P2 minimal promoter.
Facchini LM, Chen S, Marhin WW, Lear JN, Penn LZ Mol Cell Biol. 1997 Jan;17(1):100-14. PubMed

---

Articles Citing HBM-Luc

Articles
FGFR1 fusion kinase regulation of MYC expression drives development of stem cell leukemia/lymphoma syndrome. Hu T, Wu Q, Chong Y, Qin H, Poole CJ, van Riggelen J, Ren M, Cowell JK. Leukemia. 2018 Nov;32(11):2363-2373. doi: 10.1038/s41375-018-0124-y. Epub 2018 Apr 2. PubMed
Dual therapeutic targeting of MYC and JUNB transcriptional programs for enhanced anti-myeloma activity. Lind J, Aksoy O, Prchal-Murphy M, Fan F, Fulciniti M, Stoiber D, Bakiri L, Wagner EF, Zwickl-Traxler E, Sattler M, Kollmann K, Vallet S, Podar K. Blood Cancer J. 2024 Aug 19;14(1):138. doi: 10.1038/s41408-024-01117-4. PubMed

If you have published an article using this material, please email us at to have your article added to this page.